Introduction Cardiac sarcoidosis is an inflammatory granulomatous disease of the heart that carries substantial morbidity and mortality if not properly managed. Immunosuppressive therapy, often steroids, remains the cornerstone of treatment. While traditional imaging modalities help diagnose cardiac involvement, tracking the response to therapy requires reliable, repeatable biomarkers of inflammation. Recent prospective data from a study…